Masimo (MASI) Capital Expenditures Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 65.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 65.38% |
| Jan 3, 2026 | 14.52% |
| Sep 27, 2025 | 13.46% |
| Jun 28, 2025 | 5.56% |
| Mar 29, 2025 | -57.38% |
| Dec 28, 2024 | 16.98% |
| Sep 28, 2024 | -59.06% |
| Jun 29, 2024 | -69.75% |
| Mar 30, 2024 | -28.24% |
| Dec 30, 2023 | -68.45% |
| Sep 30, 2023 | 111.67% |
| Jul 1, 2023 | 25.26% |
| Apr 1, 2023 | -58.54% |
| Dec 31, 2022 | 148.67% |
| Apr 2, 2022 | 130.26% |
| Apr 3, 2021 | -75.94% |
| Sep 26, 2020 | 0.15% |
| Jun 27, 2020 | -64.67% |
| Mar 28, 2020 | 431.44% |
| Dec 28, 2019 | 155.04% |
| Sep 28, 2019 | 204.67% |
| Jun 29, 2019 | 615.35% |
| Mar 30, 2019 | 83.82% |
| Dec 29, 2018 | -17.54% |
| Sep 29, 2018 | -90.21% |
| Jun 30, 2018 | 37.01% |
| Mar 31, 2018 | -13.79% |
| Dec 30, 2017 | -2.60% |
| Sep 30, 2017 | 889.47% |
| Jul 1, 2017 | -23.57% |
| Apr 1, 2017 | -17.81% |
| Dec 31, 2016 | 136.53% |
| Apr 2, 2016 | -68.95% |
| Apr 4, 2015 | 465.45% |
| Sep 27, 2014 | 59.85% |
| Jun 28, 2014 | 2,715.83% |
| Mar 29, 2014 | 65.58% |
| Dec 28, 2013 | -6.91% |
| Sep 28, 2013 | 0.13% |
| Jun 29, 2013 | -28.41% |
| Mar 30, 2013 | -3.87% |
| Dec 29, 2012 | 74.63% |
| Sep 29, 2012 | 114.44% |
| Jun 30, 2012 | 122.74% |
| Mar 31, 2012 | 136.76% |
| Dec 31, 2011 | -76.78% |
| Apr 2, 2011 | -57.14% |